Current development and usefulness of biomarkers for Gaucher disease follow up (Q46785228)

25 December 2017

review article

1 reference

title

Current development and usefulness of biomarkers for Gaucher disease follow up (English)

1 reference

25 December 2017

1 reference

1 reference

I Maire

1

1 reference

25 December 2017

N Guffon

series ordinal

2

1 reference

25 December 2017

R Froissart

series ordinal

3

1 reference

25 December 2017

language of work or name

French

0 references

publication date

1 October 2007

1 reference

25 December 2017

Revue de Médecine Interne

published in

1 reference

25 December 2017

volume

28 Suppl 2

1 reference

25 December 2017

page(s)

S187-92

1 reference

25 December 2017

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Substrate reduction therapy of glycosphingolipid storage disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

The human chitotriosidase gene. Nature of inherited enzyme deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Evaluation of three biochemical markers in the monitoring of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Clinically relevant therapeutic endpoints in type I Gaucher disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Allelic frequency determination of the 24-bp chitotriosidase duplication in the Portuguese population by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

CCL18: a urinary marker of Gaucher cell burden in Gaucher patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Tartrate-resistant, purple acid phosphatase in Gaucher cells of the spleen. Immuno- and cytochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Plasma and metabolic abnormalities in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2807%2978880-X

7 January 2021

10.1016/S0248-8663(07)78880-X

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017